Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $213.5500 (-0.24%) ($213.5100 - $213.5500) on Wed. Nov. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.67% (three month average) | RSI | 49 | Latest Price | $213.5500(-0.24%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 0.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) FXI(25%) TBT(24%) KWEB(21%) IWF(20%) MCHI(20%) | Factors Impacting SGEN price | SGEN will decline at least -0.335% in a week (0% probabilities). XME(-93%) ONLN(-71%) XHB(-75%) GDX(-69%) ACES(-69%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.335% (StdDev 0.67%) | Hourly BBV | -2.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $213.59 | 5 Day Moving Average | $213.91(-0.17%) | 10 Day Moving Average | $213.28(0.13%) | 20 Day Moving Average | $213.59(-0.02%) | To recent high | -1.7% | To recent low | 4.5% | Market Cap | $37.129b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |